186 related articles for article (PubMed ID: 23076450)
21. Aliskiren for geriatric lowering of systolic hypertension: a randomized controlled trial.
Duprez DA; Munger MA; Botha J; Keefe DL; Charney AN
J Hum Hypertens; 2010 Sep; 24(9):600-8. PubMed ID: 20033075
[TBL] [Abstract][Full Text] [Related]
22. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
23. Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial.
Andersen K; Weinberger MH; Egan B; Constance CM; Ali MA; Jin J; Keefe DL
J Hypertens; 2008 Mar; 26(3):589-99. PubMed ID: 18300872
[TBL] [Abstract][Full Text] [Related]
24. Antihypertensive efficacy of the oral direct renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapy.
Drummond W; Munger MA; Rafique Essop M; Maboudian M; Khan M; Keefe DL
J Clin Hypertens (Greenwich); 2007 Oct; 9(10):742-50. PubMed ID: 17917501
[TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy of the oral direct renin inhibitor aliskiren in elderly patients with hypertension.
Verdecchia P; Calvo C; Möckel V; Keeling L; Satlin A
Blood Press; 2007; 16(6):381-91. PubMed ID: 18058456
[TBL] [Abstract][Full Text] [Related]
26. Comparative efficacy and safety of combination aliskiren/amlodipine and amlodipine monotherapy in African Americans with stage 2 hypertension and obesity or metabolic syndrome.
Weinberger MH; Izzo JL; Purkayastha D; Weitzman R; Black HR
J Am Soc Hypertens; 2011; 5(6):489-97. PubMed ID: 21925996
[TBL] [Abstract][Full Text] [Related]
27. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
[TBL] [Abstract][Full Text] [Related]
28. Aliskiren/amlodipine vs. aliskiren/hydrochlorothiazide in hypertension: indirect meta-analysis of trials comparing the two combinations vs. monotherapy.
Liu Y; Yan R; Song A; Niu X; Cao C; Wei J; Dong X; Gao D
Am J Hypertens; 2014 Feb; 27(2):268-78. PubMed ID: 24304656
[TBL] [Abstract][Full Text] [Related]
29. Comparative efficacy and safety of combination aliskiren/amlodipine and amlodipine monotherapy in African Americans with stage 2 hypertension.
Black HR; Weinberger MH; Purkayastha D; Lee J; Sridharan K; Israel M; Hilkert R; Izzo J
J Clin Hypertens (Greenwich); 2011 Aug; 13(8):571-81. PubMed ID: 21806767
[TBL] [Abstract][Full Text] [Related]
30. Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension.
Littlejohn TW; Trenkwalder P; Hollanders G; Zhao Y; Liao W
Curr Med Res Opin; 2009 Apr; 25(4):951-9. PubMed ID: 19257800
[TBL] [Abstract][Full Text] [Related]
31. Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: sub-analysis of a 52-week, randomized, double-blind trial.
Schmieder RE; Philipp T; Guerediaga J; Gorostidi M; Bush C; Keefe DL
J Hypertens; 2009 Jul; 27(7):1493-501. PubMed ID: 19444142
[TBL] [Abstract][Full Text] [Related]
32. Aliskiren/amlodipine (Tekamlo): another combination tablet for hypertension.
Med Lett Drugs Ther; 2010 Nov; 52(1352):94-5. PubMed ID: 21116232
[No Abstract] [Full Text] [Related]
33. A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension.
Strasser RH; Puig JG; Farsang C; Croket M; Li J; van Ingen H
J Hum Hypertens; 2007 Oct; 21(10):780-7. PubMed ID: 17541390
[TBL] [Abstract][Full Text] [Related]
34. Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies.
Gradman AH; Weir MR; Wright M; Bush CA; Keefe DL
J Hum Hypertens; 2010 Nov; 24(11):721-9. PubMed ID: 20200550
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of aliskiren-based dual and triple combination therapies in US minority patients with stage 2 hypertension.
Ferdinand KC; Weitzman R; Israel M; Lee J; Purkayastha D; Jaimes EA
J Am Soc Hypertens; 2011; 5(2):102-13. PubMed ID: 21414565
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
[TBL] [Abstract][Full Text] [Related]
37. Efficacy, safety, and tolerability of aliskiren monotherapy administered with a light meal in elderly hypertensive patients: a randomized, double-blind, placebo-controlled, dose-response evaluation study.
Villa G; Le Breton S; Ibram G; Keefe DL
J Clin Pharmacol; 2012 Dec; 52(12):1901-11. PubMed ID: 22174431
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of aliskiren/amlodipine combination and high-dose amlodipine monotherapy on endothelial function in elderly hypertensive patients.
Fukutomi M; Hoshide S; Mizuno H; Kario K
Am J Hypertens; 2014 Jan; 27(1):14-20. PubMed ID: 24008122
[TBL] [Abstract][Full Text] [Related]
40. [Comparison of benazepril monotherapy to amlodipine plus benazepril in the treatment of patients with mild and moderate hypertension: a multicentre, randomized, double-blind, parallel-controlled study].
Fan CM; Yan LR; Tao YK; Wang L; Li YQ; Gao MM; Wang YN; Li CX; Wang XW; Lu XL; Pang HM; Li YS
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):57-60. PubMed ID: 21418799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
